title: Sepsis therapy trials. Continued disappointment or reason for hope?
authors.forename: E
authors.initials: E
authors.lastname: Abraham
authors.forename: T A
authors.initials: TA
authors.lastname: Raffin
mesh_terms: D002986:Clinical Trials as Topic; D016207:Cytokines / Q000627:therapeutic use; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D009102:Multiple Organ Failure / Q000188:drug therapy; D018123:Receptors, Interleukin / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins; D012772:Shock, Septic / Q000188:drug therapy*; D012795:Sialoglycoproteins / Q000627:therapeutic use*
chemical_list: D016207:Cytokines; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D018123:Receptors, Interleukin; D011994:Recombinant Proteins; D012795:Sialoglycoproteins